Calidi Biotherapeutics, Inc. (CLDI)
NYSEAMERICAN: CLDI · Real-Time Price · USD
0.1985
-0.0120 (-5.70%)
May 11, 2026, 4:00 PM EDT - Market closed
Calidi Biotherapeutics Market Cap
Calidi Biotherapeutics has a market cap or net worth of $3.05 million as of May 11, 2026. Its market cap has decreased by -81.73% in one year.
Market Cap
3.05M
Enterprise Value
-51.01K
1-Year Change
-81.73%
Ranking
Category
Stock Price
$0.20
Market Cap Chart
Since November 1, 2021, Calidi Biotherapeutics's market cap has decreased from $273.84M to $3.05M, a decrease of -98.89%. That is a compound annual growth rate of -63.04%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 8, 2026 | 3.24M | -62.19% |
| Dec 31, 2025 | 8.56M | -61.46% |
| Dec 31, 2024 | 22.21M | -58.52% |
| Dec 29, 2023 | 53.55M | -46.69% |
| Dec 30, 2022 | 100.46M | -64.38% |
| Dec 30, 2021 | 282.04M | 2.99% |
| Nov 1, 2021 | 273.84M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Soligenix | 3.02M |
| Valion Bio | 2.76M |
| Biodexa Pharmaceuticals | 2.76M |
| AIM ImmunoTech | 2.75M |
| Oragenics | 2.59M |
| Artelo Biosciences | 2.38M |
| Bone Biologics | 2.36M |
| HCW Biologics | 2.21M |